106 related articles for article (PubMed ID: 7688381)
21. Dynamic changes in hyperglycosylated human chorionic gonadotrophin throughout the first trimester of pregnancy and its role in early placentation.
Evans J; Salamonsen LA; Menkhorst E; Dimitriadis E
Hum Reprod; 2015 May; 30(5):1029-38. PubMed ID: 25743784
[TBL] [Abstract][Full Text] [Related]
22. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
23. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
[TBL] [Abstract][Full Text] [Related]
24. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
Lelaidier C; Baton-Saint-Mleux C; Fernandez H; Bourget P; Frydman R
Hum Reprod; 1993 Mar; 8(3):492-5. PubMed ID: 8473474
[TBL] [Abstract][Full Text] [Related]
25. The mechanism of action of the copper intrauterine device.
Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
[TBL] [Abstract][Full Text] [Related]
26. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
[TBL] [Abstract][Full Text] [Related]
27. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
Permezel JM; Lenton EA; Roberts I; Cooke ID
J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
[TBL] [Abstract][Full Text] [Related]
28. The effect of mifepristone on the expression of steroid hormone receptors in human decidua and placenta: a randomized placebo-controlled double-blind study.
Chan CC; Lao TT; Ho PC; Sung EO; Cheung AN
J Clin Endocrinol Metab; 2003 Dec; 88(12):5846-50. PubMed ID: 14671179
[TBL] [Abstract][Full Text] [Related]
29. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of angiotensin II type 1 and type 2 receptors at the maternal-fetal interface: potential roles in early placental development.
Tower CL; Lui S; Charlesworth NR; Smith SD; Aplin JD; Jones RL
Reproduction; 2010 Dec; 140(6):931-42. PubMed ID: 20837730
[TBL] [Abstract][Full Text] [Related]
31. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
[TBL] [Abstract][Full Text] [Related]
32. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
[TBL] [Abstract][Full Text] [Related]
33. Mifepristone (RU 486) treatment of meningiomas.
Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
[TBL] [Abstract][Full Text] [Related]
34. Screening for cytokine mRNA in human villous and extravillous trophoblasts using the reverse-transcriptase polymerase chain reaction (RT-PCR).
King A; Jokhi PP; Smith SK; Sharkey AM; Loke YW
Cytokine; 1995 May; 7(4):364-71. PubMed ID: 8589267
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels.
Perrot-Applanat M; Deng M; Fernandez H; Lelaidier C; Meduri G; Bouchard P
J Clin Endocrinol Metab; 1994 Jan; 78(1):216-24. PubMed ID: 8288707
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
[TBL] [Abstract][Full Text] [Related]
37. The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro.
Van Voorhis BJ; Anderson DJ; Hill JA
J Clin Endocrinol Metab; 1989 Dec; 69(6):1195-9. PubMed ID: 2584354
[TBL] [Abstract][Full Text] [Related]
38. [Sex hormone receptors, prostaglandins and cAMP, in functional activity of the uterus].
Zaĭtseva TS; Morozova MS; Goncharova VN; Asribekova MK; Karpova SK; Astakhova TM; Murashko LE
Vestn Ross Akad Med Nauk; 1994; (12):13-6. PubMed ID: 7742650
[TBL] [Abstract][Full Text] [Related]
39. Betamethasone, progesterone and RU-486 (mifepristone) exert similar effects on connexin expression in trophoblast-derived HTR-8/SVneo cells.
Cervellati F; Pavan B; Lunghi L; Manni E; Fabbri E; Mascoli C; Biondi C; Patella A; Vesce F
Reprod Fertil Dev; 2011; 23(2):319-28. PubMed ID: 21211465
[TBL] [Abstract][Full Text] [Related]
40. Steroid antagonists and receptor-associated proteins.
Lebeau MC; Baulieu EE
Hum Reprod; 1994 Mar; 9(3):437-44. PubMed ID: 8006131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
